AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 132 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,000 | -99.8% | 200 | -99.4% | 0.00% | -100.0% |
| Q4 2019 | $1,063,000 | +203.7% | 31,762 | +89.8% | 0.00% | +100.0% |
| Q3 2019 | $350,000 | +239.8% | 16,732 | +340.3% | 0.00% | – |
| Q3 2018 | $103,000 | -60.1% | 3,800 | -60.5% | 0.00% | -100.0% |
| Q2 2018 | $258,000 | -74.7% | 9,611 | -70.1% | 0.00% | -97.8% |
| Q1 2018 | $1,021,000 | +3193.5% | 32,108 | +3815.6% | 0.04% | +4400.0% |
| Q4 2017 | $31,000 | +416.7% | 820 | +160.3% | 0.00% | – |
| Q2 2017 | $6,000 | -75.0% | 315 | -80.4% | 0.00% | -100.0% |
| Q3 2016 | $24,000 | – | 1,608 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|